Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic Disease
NCT00569361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2009-06-09
Summary
Using a human pangenomic microarray, the researchers established expression profiles of nasal epithelial cells, collected by brushing of patients belonging to one of four distinct groups:
1. allergic rhinitis to dust mite (AR) isolated (n=12),
2. AR associated with bronchial hyperreactivity (n=12),
3. AR associated with asthma (n=14),
4. control (n=14).
Conditions
- Allergic Rhinitis
Interventions
- PROCEDURE
-
Collection of nasal epithelial cells
Collection of nasal epithelial cells by brushing
Sponsors & Collaborators
-
ADPHUN, FRM
collaborator UNKNOWN -
Centre Hospitalier Universitaire de Nice
lead OTHER
Principal Investigators
-
Marc Albertini, Professor · Department of Pediatrics of Nice University Hospital
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-11-30
- Completion
- 2005-10-31
Countries
- France
Study Locations
More Related Trials
-
Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)
NCT00974571 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)
NCT00979901 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)
NCT00972738 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889 ·Status: COMPLETED ·Phase: NA
-
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
NCT00092885 ·Status: COMPLETED ·Phase: PHASE3
-
Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)
NCT00963599 ·Status: COMPLETED ·Phase: PHASE3
-
Viral Mucosal Reprogramming
NCT05331170 ·Status: RECRUITING ·Phase: PHASE2
-
Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
NCT01936818 ·Status: COMPLETED
-
Study Of Patients With Allergic Rhinitis And Asthma
NCT00296530 ·Status: COMPLETED ·Phase: PHASE4
-
Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)
NCT00442559 ·Status: COMPLETED ·Phase: PHASE4
-
Integrative Omics Approach to Allergic Rhinitis
NCT03324100 ·Status: ACTIVE_NOT_RECRUITING
-
The Oligonucleotide Chip Analysis for Allergic Rhinitis Treatment in Herbal Plaster and Acupuncture
NCT02486159 ·Status: COMPLETED ·Phase: NA
-
Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis
NCT04286542 ·Status: UNKNOWN ·Phase: NA
-
Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis
NCT05922176 ·Status: RECRUITING
-
Montelukast as a Controller of Atopic Syndrome
NCT00559546 ·Status: COMPLETED ·Phase: PHASE4
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Montelukast on Basophils, In-vitro
NCT00710450 ·Status: UNKNOWN
-
A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)
NCT00779545 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)
NCT01135134 ·Status: COMPLETED ·Phase: PHASE3
-
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 ·Status: COMPLETED ·Phase: PHASE4
-
Study Of Perennial Allergic Rhinitis
NCT00358475 ·Status: COMPLETED ·Phase: PHASE3
-
Eosinophil Markers and Development of Disease in Allergic Rhinitis
NCT01192386 ·Status: COMPLETED
-
Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
NCT02014623 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity
NCT00513487 ·Status: COMPLETED ·Phase: NA
-
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475 ·Status: COMPLETED